SCHEMBL6196837

SCHEMBL6196837

COC(=O)C1CCC(C#N)(c2ccc(OC(F)F)c(OC(F)F)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 20/20 0.54
PDE4A P27815 19/20 0.54
PDE4C Q08493 19/20 0.54
PDE4D Q08499 19/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6196833 1.00 PDE4B (0.54) PDE4BPDE4APDE4CPDE4D
SCHEMBL6202072 1.00 PDE4B (0.54) PDE4BPDE4APDE4CPDE4D
SCHEMBL6545615 0.91 PDE4B (0.71) PDE4BPDE4APDE4CPDE4D
SCHEMBL6199802 0.90 PDE4B (0.55) PDE4BPDE4APDE4CPDE4D
SCHEMBL5799817 0.90 PDE4B (0.55) PDE4BPDE4APDE4CPDE4D
SCHEMBL6197472 0.90 PDE4B (0.55) PDE4BPDE4APDE4CPDE4D
SCHEMBL6546019 0.87 PDE4B (0.56) PDE4BPDE4APDE4CPDE4D
SCHEMBL6196516 0.87 PDE4B (0.63) PDE4BPDE4APDE4CPDE4D
SCHEMBL6545789 0.87 PDE4B (0.56) PDE4BPDE4APDE4CPDE4D
SCHEMBL6545792 0.87 PDE4B (0.56) PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051172-B1 METHOD FOR TREATING COPD SMITHKLINE BEECHAM CORP (US) 2004-12-22 EP claimed
EP-1420011-A1 Compounds usefulfor treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 2004-05-19 EP claimed
EP-1380571-A1 Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 2004-01-14 EP claimed
EP-0919544-B1 Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORP (US) 2003-05-14 EP claimed
EP-1043994-A4 METHOD FOR TREATING MULTIPLE SCLEROSIS SMITHKLINE BEECHAM CORP (US) 2002-09-11 EP claimed
EP-1051172-A4 METHOD FOR TREATING COPD SMITHKLINE BEECHAM CORP (US) 2002-08-14 EP claimed
US-6369108-B1 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). SMITHKLINE BEECHAM CORPORATION 2002-04-09 US claimed
EP-1051172-A2 METHOD FOR TREATING COPD SMITHKLINE BEECHAM CORPORATION (US) 2000-11-15 EP claimed
EP-1043994-A1 METHOD FOR TREATING MULTIPLE SCLEROSIS SMITHKLINE BEECHAM CORPORATION (US) 2000-10-18 EP claimed
WO-1999034797-A1 METHOD FOR TREATING MULTIPLE SCLEROSIS SMITHKLINE BEECHAM CORPORATION (US) 1999-07-15 WO claimed
WO-1999034798-A1 METHOD FOR TREATING COPD SMITHKLINE BEECHAM CORPORATION (US) 1999-07-15 WO claimed
EP-0919544-A1 Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 1999-06-02 EP claimed
JP-2873090-B2 1999-03-24 JP claimed
US-5552438-A Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 1996-09-03 US claimed
EP-0633776-A4 1995-01-25 EP claimed
EP-0633776-A1 COMPOUNDS USEFUL FOR TREATING ALLERGIC AND INFLAMMATORY DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1995-01-18 EP claimed
WO-1993019749-A1 COMPOUNDS USEFUL FOR TREATING ALLERGIC AND INFLAMMATORY DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1993-10-14 WO claimed
EP-0812308-B1 METHOD FOR SYNTHESIS OF ARYL DIFLUOROMETHYL ETHERS AND THE LIKE SMITHKLINE BEECHAM CORP (US) 2005-03-16 EP disclosed
EP-0633776-A1 COMPOUNDS USEFUL FOR TREATING ALLERGIC AND INFLAMMATORY DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1995-01-18 EP disclosed
WO-1993019749-A1 COMPOUNDS USEFUL FOR TREATING ALLERGIC AND INFLAMMATORY DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1993-10-14 WO disclosed